what is retatrutide used for Promises Big Weight Loss, but Safety Remains a Question Retatrutide Half Life: A Doctor

GLP-1 and endometriosis-related cancer risk A recent study examined the effects of GLP-1 receptor agonists on incident gynecologic cancer outcomes in endometriosis patients compared to metformin

Meta-analyses of berberine trials show modest reductions in hemoglobin A1c (approximately 0.5-0.7%) and fasting glucose, with variable effects on body weight, though many studies have methodological limitations and high heterogeneity

This bone density loss occurs through several mechanisms: Rapid weight loss effects : When you lose weight quickly, you tend to lose bone density along with fat Altered calcium metabolism : GLP-1 medications may impact how your body absorbs and processes calcium Reduced mechanical loading : As weight decreases, bones experience less stress, which can signal the body to decrease bone formation Nutritional deficiencies : Decreased appetite can lead to inadequate intake of bone-building nutrients Protect your bones with our recommended comprehensive formula for GLP-1 medication users

The 176-week trial showed an average 22.9% weight loss with the 15 mg dose

[DOI] [PMC free article] [PubMed] [Google Scholar] 69